Thomas Badger
Concepts (751)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant Formula | 26 | 2023 | 152 | 7.160 |
Why?
| Soybean Proteins | 36 | 2020 | 152 | 6.450 |
Why?
| Ethanol | 41 | 2016 | 322 | 4.840 |
Why?
| Breast Feeding | 20 | 2023 | 189 | 4.550 |
Why?
| Child Development | 14 | 2018 | 204 | 4.460 |
Why?
| Diet | 31 | 2020 | 597 | 3.540 |
Why?
| Liver | 38 | 2018 | 1225 | 3.270 |
Why?
| Infant Nutritional Physiological Phenomena | 9 | 2016 | 60 | 3.080 |
Why?
| Isoflavones | 20 | 2022 | 83 | 3.060 |
Why?
| Milk | 13 | 2023 | 94 | 3.010 |
Why?
| Milk, Human | 11 | 2023 | 109 | 2.860 |
Why?
| Rats, Sprague-Dawley | 75 | 2018 | 1663 | 2.560 |
Why?
| Rats | 92 | 2016 | 3415 | 2.500 |
Why?
| Animals | 144 | 2023 | 14385 | 2.500 |
Why?
| Estradiol | 16 | 2019 | 219 | 2.370 |
Why?
| Adipose Tissue | 8 | 2019 | 207 | 2.060 |
Why?
| Soy Milk | 10 | 2018 | 39 | 2.030 |
Why?
| Obesity | 19 | 2017 | 1197 | 2.020 |
Why?
| Gene Expression Regulation | 20 | 2016 | 1062 | 1.880 |
Why?
| Body Composition | 12 | 2020 | 349 | 1.760 |
Why?
| Bottle Feeding | 8 | 2020 | 40 | 1.680 |
Why?
| Fatty Liver | 10 | 2014 | 129 | 1.630 |
Why?
| Female | 117 | 2023 | 28418 | 1.560 |
Why?
| Speech Perception | 4 | 2016 | 90 | 1.520 |
Why?
| Infant | 29 | 2023 | 3817 | 1.500 |
Why?
| Adiposity | 7 | 2019 | 142 | 1.500 |
Why?
| Male | 96 | 2023 | 27312 | 1.480 |
Why?
| Genistein | 14 | 2022 | 46 | 1.450 |
Why?
| Chromatography, Liquid | 9 | 2016 | 243 | 1.420 |
Why?
| Mass Spectrometry | 8 | 2016 | 313 | 1.410 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 6 | 2016 | 54 | 1.270 |
Why?
| RNA, Messenger | 29 | 2016 | 1202 | 1.250 |
Why?
| Cytochrome P-450 CYP2E1 | 14 | 2014 | 105 | 1.140 |
Why?
| Dietary Fats | 7 | 2014 | 142 | 1.130 |
Why?
| Overweight | 4 | 2017 | 239 | 1.130 |
Why?
| Alcohol Dehydrogenase | 10 | 2010 | 31 | 1.120 |
Why?
| Diet, High-Fat | 9 | 2019 | 216 | 1.110 |
Why?
| Dietary Carbohydrates | 4 | 2014 | 89 | 1.110 |
Why?
| Phytoestrogens | 3 | 2018 | 20 | 1.100 |
Why?
| Uterus | 5 | 2016 | 98 | 1.090 |
Why?
| Osteoblasts | 16 | 2015 | 514 | 1.070 |
Why?
| Infant Food | 6 | 2020 | 31 | 1.040 |
Why?
| Swine | 12 | 2022 | 431 | 1.030 |
Why?
| Evoked Potentials | 3 | 2016 | 69 | 1.030 |
Why?
| Pregnancy | 29 | 2023 | 2620 | 1.030 |
Why?
| Bone Density | 12 | 2016 | 416 | 1.000 |
Why?
| Vagus Nerve | 2 | 2015 | 27 | 0.990 |
Why?
| Evoked Potentials, Auditory | 3 | 2011 | 98 | 0.960 |
Why?
| Insulin | 7 | 2014 | 510 | 0.940 |
Why?
| Homeostasis | 4 | 2014 | 223 | 0.930 |
Why?
| Adiponectin | 3 | 2019 | 76 | 0.900 |
Why?
| Mammary Glands, Animal | 8 | 2013 | 69 | 0.890 |
Why?
| Brain | 11 | 2023 | 1387 | 0.880 |
Why?
| Liver Diseases, Alcoholic | 7 | 2014 | 35 | 0.870 |
Why?
| Cell Differentiation | 17 | 2015 | 720 | 0.870 |
Why?
| Sex Characteristics | 3 | 2013 | 214 | 0.870 |
Why?
| Cholesterol | 3 | 2011 | 155 | 0.840 |
Why?
| Central Nervous System Depressants | 13 | 2013 | 78 | 0.830 |
Why?
| Soy Foods | 4 | 2016 | 23 | 0.810 |
Why?
| Sex Factors | 7 | 2018 | 765 | 0.800 |
Why?
| Serum | 4 | 2018 | 39 | 0.790 |
Why?
| Signal Transduction | 23 | 2019 | 1753 | 0.790 |
Why?
| Humans | 73 | 2023 | 54246 | 0.780 |
Why?
| Weight Gain | 8 | 2019 | 243 | 0.780 |
Why?
| Infant Behavior | 2 | 2012 | 18 | 0.770 |
Why?
| Aryl Hydrocarbon Hydroxylases | 3 | 2006 | 70 | 0.750 |
Why?
| Dietary Proteins | 7 | 2012 | 229 | 0.730 |
Why?
| PPAR alpha | 7 | 2016 | 64 | 0.730 |
Why?
| Infant, Newborn | 16 | 2023 | 2907 | 0.730 |
Why?
| Testis | 2 | 2018 | 65 | 0.720 |
Why?
| Animals, Newborn | 13 | 2018 | 396 | 0.720 |
Why?
| Milk Proteins | 8 | 2017 | 76 | 0.710 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2011 | 173 | 0.710 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 5 | 2014 | 16 | 0.700 |
Why?
| Magnetic Resonance Imaging | 4 | 2021 | 1604 | 0.700 |
Why?
| Fatty Acids | 7 | 2014 | 174 | 0.690 |
Why?
| Inflammation | 9 | 2017 | 674 | 0.680 |
Why?
| Gene Expression | 10 | 2013 | 664 | 0.680 |
Why?
| GABAergic Neurons | 1 | 2018 | 14 | 0.670 |
Why?
| Agouti Signaling Protein | 2 | 2008 | 5 | 0.660 |
Why?
| Bone Resorption | 10 | 2014 | 326 | 0.660 |
Why?
| Lipid Metabolism | 7 | 2017 | 194 | 0.650 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 17 | 2016 | 673 | 0.650 |
Why?
| Longitudinal Studies | 7 | 2018 | 746 | 0.640 |
Why?
| Cytokines | 10 | 2017 | 676 | 0.640 |
Why?
| Tumor Necrosis Factor-alpha | 12 | 2016 | 434 | 0.630 |
Why?
| Promoter Regions, Genetic | 7 | 2014 | 520 | 0.620 |
Why?
| Cell Proliferation | 11 | 2016 | 1096 | 0.620 |
Why?
| Dietary Supplements | 4 | 2014 | 449 | 0.610 |
Why?
| Bone Diseases, Metabolic | 3 | 2016 | 82 | 0.610 |
Why?
| Food, Formulated | 3 | 2023 | 44 | 0.610 |
Why?
| Pregnancy Complications | 6 | 2017 | 384 | 0.600 |
Why?
| Cerebral Cortex | 2 | 2016 | 234 | 0.600 |
Why?
| Mice | 27 | 2019 | 6413 | 0.590 |
Why?
| Antineoplastic Agents, Phytogenic | 3 | 2006 | 87 | 0.590 |
Why?
| Down-Regulation | 7 | 2016 | 388 | 0.590 |
Why?
| Triglycerides | 4 | 2017 | 195 | 0.590 |
Why?
| Phonetics | 4 | 2011 | 49 | 0.580 |
Why?
| Chenodeoxycholic Acid | 1 | 2016 | 8 | 0.580 |
Why?
| Caseins | 10 | 2015 | 73 | 0.580 |
Why?
| Cell Division | 8 | 2010 | 330 | 0.560 |
Why?
| Growth | 5 | 2020 | 43 | 0.560 |
Why?
| Blotting, Western | 15 | 2016 | 683 | 0.560 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2016 | 25 | 0.560 |
Why?
| Organ Size | 10 | 2015 | 237 | 0.550 |
Why?
| Enzyme Induction | 7 | 2010 | 80 | 0.550 |
Why?
| Protein Hydrolysates | 1 | 2015 | 5 | 0.540 |
Why?
| Mammary Neoplasms, Animal | 1 | 2015 | 38 | 0.530 |
Why?
| Sexual Development | 1 | 2015 | 7 | 0.530 |
Why?
| Genitalia, Male | 1 | 2015 | 13 | 0.530 |
Why?
| DNA-Binding Proteins | 3 | 2009 | 462 | 0.520 |
Why?
| Genitalia, Female | 1 | 2015 | 20 | 0.520 |
Why?
| Child of Impaired Parents | 1 | 2015 | 46 | 0.510 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2014 | 51 | 0.510 |
Why?
| Adipocytes | 4 | 2014 | 129 | 0.510 |
Why?
| Body Fluids | 1 | 2014 | 26 | 0.510 |
Why?
| Disease Models, Animal | 13 | 2016 | 1639 | 0.500 |
Why?
| Trace Elements | 1 | 2014 | 13 | 0.500 |
Why?
| Acetylcysteine | 7 | 2010 | 118 | 0.500 |
Why?
| Bone Development | 6 | 2015 | 69 | 0.500 |
Why?
| Cytochrome P-450 CYP3A | 3 | 2010 | 82 | 0.500 |
Why?
| Apolipoproteins E | 3 | 2011 | 62 | 0.500 |
Why?
| Atherosclerosis | 4 | 2011 | 249 | 0.500 |
Why?
| Sulfates | 2 | 2006 | 27 | 0.500 |
Why?
| Cytochrome P-450 Enzyme System | 5 | 2014 | 192 | 0.490 |
Why?
| Autonomic Nervous System | 1 | 2015 | 75 | 0.490 |
Why?
| Metabolome | 3 | 2020 | 109 | 0.490 |
Why?
| Zinc | 1 | 2014 | 59 | 0.490 |
Why?
| Hippurates | 1 | 2014 | 10 | 0.480 |
Why?
| Tandem Mass Spectrometry | 2 | 2014 | 248 | 0.480 |
Why?
| Mothers | 2 | 2023 | 247 | 0.480 |
Why?
| Cell Membrane | 2 | 2006 | 278 | 0.470 |
Why?
| CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 15 | 0.470 |
Why?
| Enteral Nutrition | 7 | 2014 | 136 | 0.460 |
Why?
| Leptin | 6 | 2019 | 154 | 0.440 |
Why?
| Gene Expression Profiling | 12 | 2017 | 1138 | 0.440 |
Why?
| Child | 12 | 2023 | 7337 | 0.430 |
Why?
| Electroencephalography | 6 | 2016 | 356 | 0.430 |
Why?
| Diffusion Tensor Imaging | 5 | 2022 | 97 | 0.430 |
Why?
| Parenteral Nutrition, Total | 4 | 2010 | 26 | 0.420 |
Why?
| Hepatocytes | 3 | 2008 | 214 | 0.420 |
Why?
| Cognition | 5 | 2022 | 348 | 0.420 |
Why?
| Blastocyst | 1 | 2011 | 10 | 0.410 |
Why?
| Reactive Oxygen Species | 7 | 2016 | 491 | 0.410 |
Why?
| Transcription, Genetic | 5 | 2012 | 418 | 0.410 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2009 | 85 | 0.400 |
Why?
| Apoptosis | 9 | 2012 | 1300 | 0.400 |
Why?
| Insulin Resistance | 7 | 2016 | 300 | 0.400 |
Why?
| Body Weight | 10 | 2013 | 578 | 0.390 |
Why?
| Absorptiometry, Photon | 5 | 2020 | 174 | 0.390 |
Why?
| Hyperinsulinism | 1 | 2011 | 27 | 0.390 |
Why?
| Health | 3 | 2010 | 29 | 0.390 |
Why?
| Receptors, Steroid | 1 | 2010 | 21 | 0.390 |
Why?
| Cattle | 6 | 2020 | 224 | 0.390 |
Why?
| Umbilical Cord | 3 | 2017 | 33 | 0.390 |
Why?
| Heart | 1 | 2013 | 360 | 0.380 |
Why?
| Estrogens | 5 | 2013 | 244 | 0.380 |
Why?
| Age Factors | 5 | 2014 | 1195 | 0.380 |
Why?
| Osteogenesis | 10 | 2016 | 377 | 0.380 |
Why?
| Aging | 6 | 2016 | 784 | 0.380 |
Why?
| Dexamethasone | 2 | 2010 | 435 | 0.380 |
Why?
| Gene Expression Regulation, Enzymologic | 6 | 2010 | 206 | 0.370 |
Why?
| Oxidative Stress | 11 | 2010 | 958 | 0.370 |
Why?
| Fatty Liver, Alcoholic | 1 | 2010 | 8 | 0.370 |
Why?
| Iron | 1 | 2011 | 158 | 0.370 |
Why?
| Oligonucleotide Array Sequence Analysis | 8 | 2013 | 474 | 0.370 |
Why?
| Mammary Neoplasms, Experimental | 3 | 2006 | 135 | 0.370 |
Why?
| Alcoholism | 5 | 2008 | 249 | 0.370 |
Why?
| Genitalia | 1 | 2009 | 15 | 0.360 |
Why?
| Mice, Inbred C57BL | 14 | 2019 | 1999 | 0.360 |
Why?
| Malnutrition | 3 | 2007 | 83 | 0.360 |
Why?
| Plant Proteins | 2 | 2008 | 72 | 0.360 |
Why?
| Lipid Peroxidation | 4 | 2016 | 132 | 0.350 |
Why?
| Colonic Neoplasms | 3 | 2007 | 164 | 0.350 |
Why?
| Analysis of Variance | 5 | 2014 | 635 | 0.350 |
Why?
| Chemokine CCL2 | 2 | 2016 | 78 | 0.350 |
Why?
| PPAR gamma | 6 | 2014 | 79 | 0.350 |
Why?
| Mice, Knockout | 8 | 2019 | 926 | 0.350 |
Why?
| Breast | 1 | 2009 | 92 | 0.340 |
Why?
| Cohort Studies | 5 | 2018 | 1543 | 0.340 |
Why?
| Docosahexaenoic Acids | 1 | 2009 | 29 | 0.340 |
Why?
| Animal Feed | 5 | 2018 | 64 | 0.340 |
Why?
| Hair Color | 1 | 2008 | 10 | 0.340 |
Why?
| Protein Kinases | 2 | 2007 | 89 | 0.340 |
Why?
| Intestine, Small | 3 | 2017 | 123 | 0.330 |
Why?
| Rest | 1 | 2009 | 68 | 0.330 |
Why?
| Sulfatases | 2 | 2005 | 7 | 0.330 |
Why?
| Dose-Response Relationship, Drug | 8 | 2013 | 1476 | 0.320 |
Why?
| Glucuronidase | 2 | 2005 | 48 | 0.320 |
Why?
| Hepatitis | 1 | 2008 | 21 | 0.320 |
Why?
| Phenotype | 4 | 2014 | 820 | 0.320 |
Why?
| Glucose | 4 | 2016 | 366 | 0.320 |
Why?
| Antioxidants | 5 | 2016 | 297 | 0.320 |
Why?
| Osteogenesis, Distraction | 5 | 2007 | 72 | 0.320 |
Why?
| Cytochrome P-450 CYP1A1 | 4 | 2008 | 46 | 0.310 |
Why?
| Proliferating Cell Nuclear Antigen | 8 | 2016 | 82 | 0.310 |
Why?
| Osteocalcin | 4 | 2023 | 46 | 0.300 |
Why?
| Child, Preschool | 8 | 2021 | 4146 | 0.300 |
Why?
| Ovariectomy | 5 | 2016 | 125 | 0.300 |
Why?
| Wnt Proteins | 4 | 2012 | 110 | 0.300 |
Why?
| Triterpenes | 2 | 2005 | 13 | 0.300 |
Why?
| Time Factors | 10 | 2014 | 3212 | 0.290 |
Why?
| Cytochrome P-450 CYP1A2 | 2 | 2008 | 46 | 0.290 |
Why?
| Heart Rate | 1 | 2009 | 357 | 0.290 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 176 | 0.290 |
Why?
| Cell Line | 10 | 2014 | 1153 | 0.290 |
Why?
| Adipogenesis | 4 | 2016 | 52 | 0.290 |
Why?
| Interleukin-6 | 5 | 2016 | 315 | 0.290 |
Why?
| Lipids | 5 | 2010 | 178 | 0.290 |
Why?
| Alkylating Agents | 2 | 2014 | 22 | 0.290 |
Why?
| Colon | 4 | 2017 | 110 | 0.290 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 75 | 0.290 |
Why?
| Shiitake Mushrooms | 1 | 2006 | 5 | 0.280 |
Why?
| Animals, Suckling | 3 | 2017 | 16 | 0.280 |
Why?
| Methylnitrosourea | 2 | 2006 | 8 | 0.280 |
Why?
| Caveolin 1 | 3 | 2014 | 21 | 0.280 |
Why?
| Cells, Cultured | 13 | 2016 | 1737 | 0.280 |
Why?
| Alanine Transaminase | 5 | 2014 | 151 | 0.280 |
Why?
| Bone and Bones | 8 | 2015 | 516 | 0.280 |
Why?
| DNA Methylation | 3 | 2017 | 574 | 0.270 |
Why?
| Acetates | 1 | 2006 | 50 | 0.270 |
Why?
| beta Catenin | 3 | 2010 | 102 | 0.270 |
Why?
| Monocytes | 1 | 2006 | 156 | 0.270 |
Why?
| Beer | 1 | 2005 | 3 | 0.270 |
Why?
| Estrogen Receptor alpha | 4 | 2016 | 95 | 0.260 |
Why?
| Coumaric Acids | 2 | 2011 | 9 | 0.260 |
Why?
| Chemoprevention | 1 | 2004 | 16 | 0.260 |
Why?
| Kidney | 3 | 2007 | 820 | 0.260 |
Why?
| Oxidoreductases, N-Demethylating | 1 | 2004 | 19 | 0.260 |
Why?
| Lysophospholipids | 2 | 2008 | 34 | 0.260 |
Why?
| Glutathione Transferase | 2 | 2016 | 178 | 0.260 |
Why?
| Breast Neoplasms | 6 | 2006 | 1248 | 0.250 |
Why?
| Immunohistochemistry | 8 | 2016 | 1089 | 0.250 |
Why?
| Receptors, Aryl Hydrocarbon | 4 | 2008 | 29 | 0.250 |
Why?
| Blotting, Northern | 4 | 2006 | 108 | 0.250 |
Why?
| Necrosis | 4 | 2013 | 208 | 0.250 |
Why?
| Endotoxins | 1 | 2004 | 37 | 0.250 |
Why?
| Gastrointestinal Tract | 1 | 2006 | 135 | 0.250 |
Why?
| Orphan Nuclear Receptors | 3 | 2010 | 15 | 0.250 |
Why?
| Endothelial Cells | 1 | 2006 | 294 | 0.240 |
Why?
| Aldehydes | 3 | 2014 | 97 | 0.240 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2004 | 29 | 0.240 |
Why?
| Language Development | 2 | 2016 | 31 | 0.240 |
Why?
| Carbohydrates | 1 | 2004 | 64 | 0.240 |
Why?
| NF-kappa B | 3 | 2011 | 335 | 0.240 |
Why?
| Steroid 16-alpha-Hydroxylase | 1 | 2003 | 6 | 0.240 |
Why?
| Anisotropy | 3 | 2022 | 63 | 0.240 |
Why?
| Immunoprecipitation | 5 | 2013 | 73 | 0.240 |
Why?
| Alcohols | 1 | 2003 | 8 | 0.230 |
Why?
| Phytosterols | 1 | 2003 | 5 | 0.230 |
Why?
| Birth Weight | 2 | 2015 | 126 | 0.230 |
Why?
| Alcoholic Intoxication | 1 | 2003 | 24 | 0.230 |
Why?
| Ovary | 2 | 2016 | 105 | 0.230 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 101 | 0.220 |
Why?
| Membrane Glycoproteins | 2 | 2015 | 269 | 0.220 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 4 | 0.220 |
Why?
| Child Language | 2 | 2014 | 11 | 0.220 |
Why?
| Proto-Oncogene Proteins | 1 | 2003 | 169 | 0.220 |
Why?
| Gastrointestinal Neoplasms | 1 | 2003 | 46 | 0.220 |
Why?
| Nutrition Surveys | 1 | 2023 | 121 | 0.220 |
Why?
| Diffusion Magnetic Resonance Imaging | 3 | 2022 | 126 | 0.220 |
Why?
| Fruit | 3 | 2012 | 142 | 0.210 |
Why?
| Glucuronides | 1 | 2002 | 57 | 0.210 |
Why?
| Plethysmography | 2 | 2012 | 45 | 0.210 |
Why?
| Cell Line, Tumor | 6 | 2006 | 1550 | 0.210 |
Why?
| Beverages | 1 | 2002 | 83 | 0.210 |
Why?
| Tibia | 8 | 2016 | 117 | 0.210 |
Why?
| Carcinogens | 3 | 2015 | 231 | 0.210 |
Why?
| Placenta | 2 | 2014 | 135 | 0.210 |
Why?
| Lactation | 3 | 2012 | 61 | 0.210 |
Why?
| Reproduction | 1 | 2022 | 56 | 0.210 |
Why?
| Depressive Disorder, Major | 1 | 2023 | 159 | 0.200 |
Why?
| Memory | 2 | 2020 | 124 | 0.200 |
Why?
| Bacteria | 3 | 2020 | 258 | 0.200 |
Why?
| Models, Animal | 5 | 2014 | 255 | 0.200 |
Why?
| Prostatic Neoplasms | 1 | 2005 | 415 | 0.200 |
Why?
| Urinalysis | 1 | 2020 | 50 | 0.190 |
Why?
| Weaning | 4 | 2014 | 29 | 0.190 |
Why?
| Body Mass Index | 2 | 2015 | 712 | 0.190 |
Why?
| Neuropsychological Tests | 3 | 2020 | 363 | 0.190 |
Why?
| Ultrasonography | 2 | 2015 | 480 | 0.190 |
Why?
| Malondialdehyde | 3 | 2005 | 63 | 0.190 |
Why?
| Prospective Studies | 4 | 2019 | 2604 | 0.180 |
Why?
| Energy Metabolism | 3 | 2013 | 311 | 0.180 |
Why?
| Osteoporosis | 2 | 2012 | 164 | 0.180 |
Why?
| Macrophages | 4 | 2011 | 405 | 0.180 |
Why?
| Overnutrition | 2 | 2011 | 10 | 0.180 |
Why?
| Hypercholesterolemia | 2 | 2010 | 42 | 0.180 |
Why?
| Feces | 1 | 2020 | 135 | 0.180 |
Why?
| Executive Function | 1 | 2020 | 80 | 0.180 |
Why?
| Receptor Cross-Talk | 1 | 2019 | 7 | 0.180 |
Why?
| Brain Mapping | 3 | 2021 | 250 | 0.180 |
Why?
| Liver Neoplasms, Experimental | 2 | 2014 | 48 | 0.180 |
Why?
| Early Growth Response Protein 1 | 2 | 2016 | 39 | 0.170 |
Why?
| Binding Sites | 3 | 2006 | 440 | 0.170 |
Why?
| Endocrine System | 2 | 2009 | 12 | 0.170 |
Why?
| Follow-Up Studies | 2 | 2016 | 2387 | 0.170 |
Why?
| Immunity, Humoral | 1 | 2018 | 25 | 0.170 |
Why?
| RANK Ligand | 4 | 2013 | 183 | 0.170 |
Why?
| Immunity, Cellular | 1 | 2018 | 80 | 0.170 |
Why?
| Purines | 1 | 2018 | 45 | 0.160 |
Why?
| Energy Intake | 4 | 2008 | 196 | 0.160 |
Why?
| Spectrum Analysis | 2 | 2009 | 79 | 0.160 |
Why?
| Osteoclasts | 5 | 2013 | 469 | 0.160 |
Why?
| Midazolam | 2 | 2010 | 42 | 0.160 |
Why?
| Exosomes | 1 | 2018 | 45 | 0.160 |
Why?
| Metabolomics | 2 | 2020 | 149 | 0.160 |
Why?
| Neoplasms | 2 | 2006 | 1315 | 0.160 |
Why?
| Models, Biological | 3 | 2014 | 823 | 0.160 |
Why?
| Androgens | 1 | 2018 | 68 | 0.160 |
Why?
| Regression Analysis | 2 | 2017 | 445 | 0.160 |
Why?
| Tryptamines | 1 | 2017 | 9 | 0.160 |
Why?
| Follicular Fluid | 1 | 2017 | 11 | 0.150 |
Why?
| Cadherins | 2 | 2016 | 72 | 0.150 |
Why?
| Enzyme Inhibitors | 3 | 2010 | 446 | 0.150 |
Why?
| Bone Remodeling | 2 | 2016 | 177 | 0.150 |
Why?
| Steroid Hydroxylases | 2 | 2007 | 12 | 0.150 |
Why?
| Anticarcinogenic Agents | 3 | 2006 | 35 | 0.150 |
Why?
| Anticholesteremic Agents | 2 | 2009 | 34 | 0.150 |
Why?
| Tryptophan | 1 | 2017 | 102 | 0.150 |
Why?
| Oocytes | 1 | 2017 | 94 | 0.150 |
Why?
| Functional Laterality | 2 | 2007 | 99 | 0.140 |
Why?
| Parents | 1 | 2019 | 344 | 0.140 |
Why?
| Pregnancy, Animal | 2 | 2006 | 30 | 0.140 |
Why?
| Hydrogen Peroxide | 2 | 2016 | 142 | 0.140 |
Why?
| Interleukin-1 | 3 | 2005 | 107 | 0.140 |
Why?
| Metabolic Clearance Rate | 2 | 2007 | 75 | 0.140 |
Why?
| Corn Oil | 2 | 2007 | 13 | 0.140 |
Why?
| C-Reactive Protein | 1 | 2017 | 159 | 0.140 |
Why?
| Serotonin | 1 | 2017 | 159 | 0.140 |
Why?
| Catalase | 1 | 2016 | 74 | 0.140 |
Why?
| Ki-67 Antigen | 1 | 2016 | 63 | 0.140 |
Why?
| Reaction Time | 2 | 2007 | 227 | 0.140 |
Why?
| Chromatin Immunoprecipitation | 3 | 2010 | 55 | 0.140 |
Why?
| Sequence Analysis, RNA | 2 | 2017 | 107 | 0.140 |
Why?
| Phenylpropionates | 2 | 2007 | 13 | 0.140 |
Why?
| Protein Transport | 3 | 2010 | 195 | 0.140 |
Why?
| Glutathione | 3 | 2008 | 330 | 0.130 |
Why?
| Phosphorylation | 3 | 2010 | 614 | 0.130 |
Why?
| Cell Nucleus | 3 | 2010 | 203 | 0.130 |
Why?
| Protective Agents | 1 | 2015 | 20 | 0.130 |
Why?
| Disease Susceptibility | 2 | 2012 | 95 | 0.130 |
Why?
| Random Allocation | 5 | 2016 | 312 | 0.130 |
Why?
| Feeding Behavior | 2 | 2017 | 199 | 0.130 |
Why?
| Fetus | 2 | 2007 | 227 | 0.130 |
Why?
| Species Specificity | 2 | 2006 | 205 | 0.130 |
Why?
| Mitochondrial Dynamics | 1 | 2014 | 22 | 0.130 |
Why?
| Intelligence Tests | 1 | 2014 | 44 | 0.130 |
Why?
| Antigens, CD | 1 | 2016 | 242 | 0.130 |
Why?
| Apoproteins | 2 | 2005 | 11 | 0.130 |
Why?
| MicroRNAs | 1 | 2018 | 386 | 0.120 |
Why?
| Free Radicals | 2 | 2004 | 31 | 0.120 |
Why?
| Diethylnitrosamine | 1 | 2014 | 19 | 0.120 |
Why?
| Intelligence | 1 | 2014 | 63 | 0.120 |
Why?
| DNA, Complementary | 2 | 2004 | 145 | 0.120 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 14 | 0.120 |
Why?
| Bile Acids and Salts | 1 | 2014 | 76 | 0.120 |
Why?
| Insulin-Like Growth Factor I | 5 | 2019 | 137 | 0.120 |
Why?
| Base Sequence | 2 | 2006 | 719 | 0.120 |
Why?
| Adult | 7 | 2019 | 14182 | 0.120 |
Why?
| Transcriptome | 4 | 2018 | 346 | 0.120 |
Why?
| Epithelial Cells | 2 | 2006 | 255 | 0.120 |
Why?
| Response Elements | 2 | 2010 | 32 | 0.120 |
Why?
| MAP Kinase Signaling System | 2 | 2011 | 133 | 0.120 |
Why?
| Circadian Rhythm | 1 | 2014 | 85 | 0.120 |
Why?
| Health Status | 2 | 2009 | 368 | 0.120 |
Why?
| Wnt Signaling Pathway | 1 | 2014 | 94 | 0.120 |
Why?
| Real-Time Polymerase Chain Reaction | 4 | 2016 | 206 | 0.120 |
Why?
| Microarray Analysis | 3 | 2014 | 84 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2014 | 151 | 0.120 |
Why?
| Growth and Development | 1 | 2013 | 16 | 0.110 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2013 | 47 | 0.110 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2012 | 51 | 0.110 |
Why?
| Adipose Tissue, White | 1 | 2013 | 39 | 0.110 |
Why?
| Stromal Cells | 1 | 2013 | 79 | 0.110 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2010 | 93 | 0.110 |
Why?
| Genome | 1 | 2013 | 74 | 0.110 |
Why?
| Zea mays | 1 | 2013 | 18 | 0.110 |
Why?
| Fatty Acids, Unsaturated | 1 | 2013 | 46 | 0.110 |
Why?
| Skull | 4 | 2016 | 79 | 0.110 |
Why?
| Estrogen Receptor beta | 2 | 2013 | 56 | 0.110 |
Why?
| Peyer's Patches | 2 | 2016 | 11 | 0.110 |
Why?
| Body Water | 1 | 2012 | 34 | 0.110 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 99 | 0.110 |
Why?
| Cell Separation | 1 | 2013 | 107 | 0.110 |
Why?
| Mitochondria, Liver | 1 | 2013 | 86 | 0.110 |
Why?
| Mammary Glands, Human | 1 | 2012 | 15 | 0.110 |
Why?
| Morphogenesis | 1 | 2012 | 20 | 0.110 |
Why?
| Bone Matrix | 1 | 2012 | 20 | 0.110 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2012 | 36 | 0.110 |
Why?
| Cholecalciferol | 2 | 2012 | 25 | 0.110 |
Why?
| Vitamins | 1 | 2012 | 72 | 0.110 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2014 | 250 | 0.110 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2013 | 253 | 0.110 |
Why?
| Flavones | 1 | 2011 | 5 | 0.110 |
Why?
| Prenatal Nutritional Physiological Phenomena | 2 | 2014 | 9 | 0.110 |
Why?
| Software | 1 | 2014 | 296 | 0.110 |
Why?
| Interleukin-8 | 2 | 2016 | 97 | 0.100 |
Why?
| Proteins | 2 | 2017 | 376 | 0.100 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 153 | 0.100 |
Why?
| Macrophage Activation | 1 | 2011 | 29 | 0.100 |
Why?
| Mice, Mutant Strains | 2 | 2011 | 84 | 0.100 |
Why?
| Acids, Carbocyclic | 1 | 2011 | 3 | 0.100 |
Why?
| Alcohol Drinking | 1 | 2014 | 259 | 0.100 |
Why?
| Vitamin D | 1 | 2012 | 101 | 0.100 |
Why?
| Foam Cells | 1 | 2011 | 16 | 0.100 |
Why?
| Sus scrofa | 1 | 2011 | 39 | 0.100 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2011 | 31 | 0.100 |
Why?
| Sirtuin 3 | 1 | 2011 | 17 | 0.100 |
Why?
| Plant Preparations | 1 | 2011 | 38 | 0.100 |
Why?
| Scavenger Receptors, Class A | 1 | 2011 | 38 | 0.100 |
Why?
| Homeodomain Proteins | 1 | 2011 | 82 | 0.100 |
Why?
| Milk Substitutes | 1 | 2010 | 6 | 0.100 |
Why?
| Agaricales | 1 | 2010 | 4 | 0.100 |
Why?
| RNA | 4 | 2018 | 202 | 0.100 |
Why?
| Speech Acoustics | 1 | 2010 | 21 | 0.100 |
Why?
| Risk Factors | 3 | 2012 | 3930 | 0.100 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2011 | 169 | 0.100 |
Why?
| Hydroxybenzoates | 1 | 2010 | 23 | 0.100 |
Why?
| Fats | 1 | 2010 | 3 | 0.100 |
Why?
| Collagen | 1 | 2012 | 223 | 0.100 |
Why?
| Disease Progression | 1 | 2014 | 913 | 0.100 |
Why?
| Retinoid X Receptors | 1 | 2010 | 16 | 0.100 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 70 | 0.100 |
Why?
| Aorta | 2 | 2010 | 177 | 0.090 |
Why?
| Resistin | 1 | 2010 | 6 | 0.090 |
Why?
| Adenylate Kinase | 1 | 2010 | 10 | 0.090 |
Why?
| Arkansas | 2 | 2015 | 2094 | 0.090 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 17 | 0.090 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 142 | 0.090 |
Why?
| Up-Regulation | 4 | 2016 | 508 | 0.090 |
Why?
| Allyl Compounds | 1 | 2010 | 9 | 0.090 |
Why?
| Aldehyde Dehydrogenase | 2 | 2007 | 27 | 0.090 |
Why?
| Sulfides | 1 | 2010 | 32 | 0.090 |
Why?
| Administration, Oral | 3 | 2006 | 459 | 0.090 |
Why?
| Diet, Carbohydrate-Restricted | 1 | 2009 | 8 | 0.090 |
Why?
| RNA Interference | 2 | 2011 | 195 | 0.090 |
Why?
| Carbohydrate Metabolism | 1 | 2009 | 31 | 0.090 |
Why?
| Adolescent | 3 | 2017 | 6885 | 0.090 |
Why?
| Language | 2 | 2021 | 138 | 0.090 |
Why?
| Fibroblast Growth Factors | 1 | 2010 | 59 | 0.090 |
Why?
| Chemokines | 1 | 2010 | 96 | 0.090 |
Why?
| Single-Blind Method | 1 | 2009 | 120 | 0.090 |
Why?
| Antibodies | 2 | 2014 | 178 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 314 | 0.090 |
Why?
| Regeneration | 1 | 2010 | 72 | 0.090 |
Why?
| Lipopolysaccharides | 2 | 2011 | 199 | 0.090 |
Why?
| Neuroimaging | 2 | 2020 | 88 | 0.090 |
Why?
| Pyrazoles | 1 | 2010 | 110 | 0.090 |
Why?
| Endoplasmic Reticulum | 1 | 2010 | 123 | 0.090 |
Why?
| Prostate | 1 | 2009 | 117 | 0.080 |
Why?
| Gene Regulatory Networks | 1 | 2009 | 124 | 0.080 |
Why?
| Calcium | 2 | 2016 | 432 | 0.080 |
Why?
| Mice, Inbred Strains | 1 | 2008 | 198 | 0.080 |
Why?
| Tumor Cells, Cultured | 2 | 2006 | 477 | 0.080 |
Why?
| Testosterone | 2 | 2007 | 119 | 0.080 |
Why?
| Plant Extracts | 1 | 2010 | 193 | 0.080 |
Why?
| Research Design | 1 | 2010 | 374 | 0.080 |
Why?
| Anthropometry | 2 | 2020 | 96 | 0.080 |
Why?
| Seeds | 1 | 2007 | 31 | 0.080 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2012 | 48 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 490 | 0.080 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2007 | 67 | 0.080 |
Why?
| Chromatin | 2 | 2007 | 156 | 0.080 |
Why?
| Umbilical Veins | 1 | 2006 | 23 | 0.070 |
Why?
| Femur | 3 | 2016 | 144 | 0.070 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2006 | 5 | 0.070 |
Why?
| Acoustic Stimulation | 1 | 2007 | 99 | 0.070 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2006 | 15 | 0.070 |
Why?
| Macaca fascicularis | 1 | 2006 | 9 | 0.070 |
Why?
| Choline Deficiency | 1 | 2006 | 23 | 0.070 |
Why?
| Chemokine CXCL2 | 2 | 2017 | 14 | 0.070 |
Why?
| Cyclin D1 | 1 | 2006 | 60 | 0.070 |
Why?
| Vitamin E | 1 | 2007 | 107 | 0.070 |
Why?
| Ileum | 2 | 2017 | 102 | 0.070 |
Why?
| Naphthols | 1 | 2006 | 10 | 0.070 |
Why?
| Coculture Techniques | 1 | 2006 | 160 | 0.070 |
Why?
| Chromones | 1 | 2006 | 16 | 0.070 |
Why?
| Threonine | 1 | 2006 | 17 | 0.070 |
Why?
| Cell Adhesion | 1 | 2006 | 171 | 0.070 |
Why?
| bcl-2-Associated X Protein | 1 | 2006 | 73 | 0.070 |
Why?
| C-Peptide | 1 | 2005 | 24 | 0.070 |
Why?
| Transcription Factors | 2 | 2014 | 622 | 0.070 |
Why?
| Leukocytes, Mononuclear | 1 | 2006 | 133 | 0.070 |
Why?
| Colonic Diseases | 1 | 2005 | 13 | 0.070 |
Why?
| Estrus | 1 | 2005 | 11 | 0.070 |
Why?
| Lymphotoxin-alpha | 1 | 2005 | 10 | 0.070 |
Why?
| Kupffer Cells | 1 | 2005 | 18 | 0.070 |
Why?
| Sulfotransferases | 1 | 2006 | 43 | 0.070 |
Why?
| False Negative Reactions | 1 | 2005 | 36 | 0.070 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 110 | 0.070 |
Why?
| Morpholines | 1 | 2006 | 64 | 0.070 |
Why?
| Subcellular Fractions | 1 | 2005 | 43 | 0.070 |
Why?
| Hydrolysis | 1 | 2005 | 68 | 0.070 |
Why?
| Alkaline Phosphatase | 3 | 2012 | 99 | 0.070 |
Why?
| Cytochromes b5 | 1 | 2005 | 7 | 0.070 |
Why?
| Oxidants | 1 | 2005 | 64 | 0.070 |
Why?
| Plasmids | 1 | 2006 | 180 | 0.070 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2005 | 24 | 0.070 |
Why?
| Cytosol | 1 | 2005 | 101 | 0.070 |
Why?
| Injections, Intravenous | 1 | 2005 | 148 | 0.070 |
Why?
| NADPH-Ferrihemoprotein Reductase | 1 | 2005 | 22 | 0.070 |
Why?
| Immune System | 1 | 2005 | 49 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 1 | 2005 | 194 | 0.070 |
Why?
| Tissue Distribution | 1 | 2005 | 178 | 0.070 |
Why?
| Methionine | 1 | 2006 | 146 | 0.070 |
Why?
| Area Under Curve | 1 | 2005 | 205 | 0.070 |
Why?
| Clotrimazole | 1 | 2004 | 3 | 0.070 |
Why?
| DNA Probes | 1 | 2004 | 27 | 0.060 |
Why?
| Bone Regeneration | 1 | 2005 | 71 | 0.060 |
Why?
| DNA Primers | 3 | 2014 | 225 | 0.060 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 64 | 0.060 |
Why?
| DNA Repair | 1 | 2006 | 202 | 0.060 |
Why?
| Fracture Healing | 1 | 2004 | 26 | 0.060 |
Why?
| Polymerase Chain Reaction | 3 | 2016 | 531 | 0.060 |
Why?
| Receptors, Progesterone | 1 | 2004 | 57 | 0.060 |
Why?
| Isoenzymes | 1 | 2005 | 177 | 0.060 |
Why?
| Saponins | 1 | 2004 | 7 | 0.060 |
Why?
| Lipoproteins, LDL | 1 | 2006 | 195 | 0.060 |
Why?
| Sterol Regulatory Element Binding Protein 2 | 1 | 2004 | 2 | 0.060 |
Why?
| Ribonucleases | 1 | 2004 | 4 | 0.060 |
Why?
| Cell Cycle | 1 | 2006 | 275 | 0.060 |
Why?
| Receptor, erbB-2 | 1 | 2004 | 79 | 0.060 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2006 | 140 | 0.060 |
Why?
| Precipitin Tests | 1 | 2004 | 39 | 0.060 |
Why?
| Cholesterol 7-alpha-Hydroxylase | 1 | 2004 | 7 | 0.060 |
Why?
| Hydrocarbons, Fluorinated | 1 | 2004 | 8 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2005 | 141 | 0.060 |
Why?
| Ultraviolet Rays | 1 | 2004 | 56 | 0.060 |
Why?
| Hyperplasia | 1 | 2004 | 107 | 0.060 |
Why?
| Fatty Acids, Nonesterified | 2 | 2014 | 55 | 0.060 |
Why?
| Immunoblotting | 2 | 2016 | 134 | 0.060 |
Why?
| Microsomes, Liver | 1 | 2005 | 214 | 0.060 |
Why?
| Molecular Sequence Data | 1 | 2006 | 980 | 0.060 |
Why?
| DNA Damage | 1 | 2006 | 357 | 0.060 |
Why?
| STAT5 Transcription Factor | 1 | 2003 | 9 | 0.060 |
Why?
| Rats, Wistar | 1 | 2004 | 237 | 0.060 |
Why?
| Postmenopause | 1 | 2004 | 102 | 0.060 |
Why?
| Janus Kinase 2 | 1 | 2003 | 31 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 293 | 0.060 |
Why?
| Folic Acid | 1 | 2004 | 139 | 0.060 |
Why?
| Models, Genetic | 1 | 2004 | 209 | 0.060 |
Why?
| Calorimetry, Indirect | 2 | 2014 | 29 | 0.060 |
Why?
| Indicators and Reagents | 1 | 2003 | 42 | 0.060 |
Why?
| Case-Control Studies | 2 | 2017 | 1228 | 0.060 |
Why?
| Odds Ratio | 1 | 2005 | 604 | 0.060 |
Why?
| Sulfonamides | 1 | 2004 | 146 | 0.060 |
Why?
| Binding, Competitive | 1 | 2002 | 113 | 0.050 |
Why?
| Bone Marrow | 3 | 2012 | 411 | 0.050 |
Why?
| Sialoglycoproteins | 1 | 2002 | 9 | 0.050 |
Why?
| Trans-Activators | 1 | 2003 | 147 | 0.050 |
Why?
| Genotype | 2 | 2014 | 599 | 0.050 |
Why?
| Carcinoma, Squamous Cell | 1 | 2006 | 384 | 0.050 |
Why?
| Asia | 1 | 2002 | 32 | 0.050 |
Why?
| Melanoma | 1 | 2006 | 313 | 0.050 |
Why?
| Oligonucleotides | 1 | 2002 | 76 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2003 | 193 | 0.050 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2003 | 377 | 0.050 |
Why?
| Incidence | 1 | 2005 | 1082 | 0.050 |
Why?
| Antibodies, Monoclonal | 1 | 2006 | 562 | 0.050 |
Why?
| Health Promotion | 1 | 2004 | 300 | 0.050 |
Why?
| Kinetics | 1 | 2002 | 692 | 0.050 |
Why?
| Receptors, Estrogen | 2 | 2013 | 131 | 0.050 |
Why?
| Lipogenesis | 2 | 2013 | 34 | 0.050 |
Why?
| Middle Aged | 3 | 2006 | 13070 | 0.050 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 2 | 2012 | 27 | 0.050 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2006 | 481 | 0.050 |
Why?
| Young Adult | 2 | 2019 | 4308 | 0.040 |
Why?
| Tomography, X-Ray Computed | 3 | 2012 | 1213 | 0.040 |
Why?
| Depression | 1 | 2023 | 594 | 0.040 |
Why?
| Gestational Age | 1 | 2019 | 435 | 0.040 |
Why?
| Nerve Net | 1 | 2018 | 74 | 0.040 |
Why?
| Acinetobacter | 1 | 2017 | 7 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.040 |
Why?
| Aminoisobutyric Acids | 1 | 2017 | 9 | 0.040 |
Why?
| Clostridium | 1 | 2017 | 18 | 0.040 |
Why?
| Oocyte Retrieval | 1 | 2017 | 6 | 0.040 |
Why?
| Streptococcus | 1 | 2017 | 15 | 0.040 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2017 | 7 | 0.040 |
Why?
| Ovulation Induction | 1 | 2017 | 14 | 0.040 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2017 | 10 | 0.040 |
Why?
| AMP-Activated Protein Kinases | 1 | 2017 | 29 | 0.040 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2010 | 40 | 0.040 |
Why?
| Duodenum | 1 | 2017 | 36 | 0.040 |
Why?
| RNA, Ribosomal, 16S | 1 | 2017 | 106 | 0.040 |
Why?
| Azoxymethane | 2 | 2007 | 8 | 0.040 |
Why?
| Single-Cell Analysis | 1 | 2017 | 56 | 0.040 |
Why?
| Carnitine | 1 | 2017 | 86 | 0.040 |
Why?
| Recombinant Proteins | 2 | 2010 | 569 | 0.040 |
Why?
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.040 |
Why?
| Chemokine CXCL11 | 1 | 2016 | 6 | 0.040 |
Why?
| Granulosa Cells | 1 | 2016 | 12 | 0.040 |
Why?
| Versicans | 1 | 2016 | 10 | 0.040 |
Why?
| Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.040 |
Why?
| Chemokine CXCL10 | 1 | 2016 | 20 | 0.040 |
Why?
| Receptors, CCR2 | 1 | 2016 | 14 | 0.040 |
Why?
| Monosaccharide Transport Proteins | 1 | 2016 | 15 | 0.040 |
Why?
| Tissue Array Analysis | 1 | 2016 | 50 | 0.040 |
Why?
| Thinness | 1 | 2016 | 57 | 0.040 |
Why?
| Interleukin-9 | 1 | 2016 | 8 | 0.040 |
Why?
| Leukemia Inhibitory Factor | 1 | 2016 | 15 | 0.040 |
Why?
| Fas Ligand Protein | 1 | 2016 | 21 | 0.040 |
Why?
| Interleukin-15 | 1 | 2016 | 19 | 0.040 |
Why?
| Progesterone | 2 | 2006 | 69 | 0.030 |
Why?
| Interferon-alpha | 1 | 2016 | 50 | 0.030 |
Why?
| Thiazolidinediones | 1 | 2016 | 95 | 0.030 |
Why?
| United States | 2 | 2010 | 5200 | 0.030 |
Why?
| Jejunum | 1 | 2016 | 56 | 0.030 |
Why?
| Genetic Variation | 1 | 2017 | 253 | 0.030 |
Why?
| Phosphoproteins | 1 | 2016 | 116 | 0.030 |
Why?
| Mutation | 1 | 2002 | 1501 | 0.030 |
Why?
| Interleukin-10 | 1 | 2016 | 107 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 2017 | 199 | 0.030 |
Why?
| Carrier Proteins | 1 | 2017 | 359 | 0.030 |
Why?
| Tissue Plasminogen Activator | 1 | 2016 | 124 | 0.030 |
Why?
| Muscle, Skeletal | 2 | 2014 | 847 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 21 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2016 | 230 | 0.030 |
Why?
| Animal Nutritional Physiological Phenomena | 1 | 2014 | 17 | 0.030 |
Why?
| Metalloproteases | 1 | 2014 | 10 | 0.030 |
Why?
| PTEN Phosphohydrolase | 2 | 2005 | 61 | 0.030 |
Why?
| Matrix Metalloproteinases | 1 | 2014 | 52 | 0.030 |
Why?
| GTP Phosphohydrolases | 1 | 2014 | 35 | 0.030 |
Why?
| Neoplasm Proteins | 1 | 2017 | 359 | 0.030 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 14 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 65 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 100 | 0.030 |
Why?
| Transcription Initiation Site | 1 | 2014 | 13 | 0.030 |
Why?
| Actins | 1 | 2014 | 132 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2016 | 656 | 0.030 |
Why?
| Biological Clocks | 1 | 2014 | 19 | 0.030 |
Why?
| Fibrosis | 1 | 2014 | 208 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2014 | 87 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 158 | 0.030 |
Why?
| Sirtuin 1 | 1 | 2014 | 29 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2014 | 165 | 0.030 |
Why?
| Mitochondrial Proteins | 1 | 2014 | 121 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 95 | 0.030 |
Why?
| Osteoprotegerin | 1 | 2013 | 57 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 128 | 0.030 |
Why?
| Lysine | 1 | 2014 | 102 | 0.030 |
Why?
| Deuterium Oxide | 1 | 2012 | 9 | 0.030 |
Why?
| Air | 1 | 2012 | 26 | 0.030 |
Why?
| Activating Transcription Factor 3 | 1 | 2012 | 9 | 0.030 |
Why?
| Sexual Maturation | 1 | 2012 | 13 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2013 | 233 | 0.030 |
Why?
| SOX Transcription Factors | 1 | 2012 | 4 | 0.030 |
Why?
| GATA Transcription Factors | 1 | 2012 | 4 | 0.030 |
Why?
| Calcitonin | 1 | 2012 | 38 | 0.030 |
Why?
| Phytotherapy | 1 | 2012 | 38 | 0.030 |
Why?
| Arecaceae | 1 | 2011 | 4 | 0.030 |
Why?
| Luteolin | 1 | 2011 | 5 | 0.030 |
Why?
| Apigenin | 1 | 2011 | 5 | 0.030 |
Why?
| Genetic Markers | 1 | 2012 | 117 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2011 | 68 | 0.030 |
Why?
| Membrane Proteins | 1 | 2014 | 389 | 0.030 |
Why?
| Metabolic Diseases | 1 | 2012 | 43 | 0.030 |
Why?
| Cell Line, Transformed | 1 | 2011 | 88 | 0.030 |
Why?
| Myofibrils | 1 | 2011 | 21 | 0.030 |
Why?
| Myosins | 1 | 2011 | 19 | 0.030 |
Why?
| Cell Shape | 1 | 2011 | 23 | 0.030 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 64 | 0.030 |
Why?
| Macrophages, Peritoneal | 1 | 2011 | 32 | 0.030 |
Why?
| Receptors, Scavenger | 1 | 2011 | 28 | 0.030 |
Why?
| Flavonoids | 1 | 2011 | 62 | 0.030 |
Why?
| Histones | 1 | 2014 | 335 | 0.020 |
Why?
| Multiple Myeloma | 1 | 2006 | 3035 | 0.020 |
Why?
| Forkhead Transcription Factors | 1 | 2012 | 118 | 0.020 |
Why?
| Onium Compounds | 1 | 2010 | 14 | 0.020 |
Why?
| Hedgehog Proteins | 1 | 2010 | 33 | 0.020 |
Why?
| Intestines | 1 | 2012 | 204 | 0.020 |
Why?
| Liver Regeneration | 1 | 2010 | 57 | 0.020 |
Why?
| TCF Transcription Factors | 1 | 2010 | 11 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2010 | 21 | 0.020 |
Why?
| Preventive Medicine | 1 | 2010 | 23 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 2011 | 423 | 0.020 |
Why?
| Drug Therapy | 1 | 2010 | 50 | 0.020 |
Why?
| Fourier Analysis | 1 | 2010 | 22 | 0.020 |
Why?
| Biological Availability | 1 | 2010 | 131 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 923 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2010 | 16 | 0.020 |
Why?
| Cell Lineage | 1 | 2010 | 93 | 0.020 |
Why?
| National Institutes of Health (U.S.) | 1 | 2010 | 49 | 0.020 |
Why?
| Solubility | 1 | 2010 | 75 | 0.020 |
Why?
| Scalp | 1 | 2010 | 53 | 0.020 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2010 | 92 | 0.020 |
Why?
| beta-Galactosidase | 1 | 2009 | 42 | 0.020 |
Why?
| Biomedical Research | 1 | 2012 | 240 | 0.020 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 24 | 0.020 |
Why?
| Genes, Reporter | 1 | 2009 | 98 | 0.020 |
Why?
| Liver Function Tests | 1 | 2008 | 43 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2012 | 1304 | 0.020 |
Why?
| Radiography | 1 | 2010 | 524 | 0.020 |
Why?
| Ligands | 1 | 2009 | 230 | 0.020 |
Why?
| Eating | 1 | 2009 | 155 | 0.020 |
Why?
| Free Radical Scavengers | 1 | 2008 | 35 | 0.020 |
Why?
| Epigenesis, Genetic | 1 | 2011 | 399 | 0.020 |
Why?
| Wound Healing | 1 | 2010 | 228 | 0.020 |
Why?
| Estrogens, Non-Steroidal | 1 | 2007 | 14 | 0.020 |
Why?
| Calcitriol | 1 | 2007 | 40 | 0.020 |
Why?
| Autoantibodies | 1 | 2008 | 132 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2007 | 19 | 0.020 |
Why?
| Glucose Transporter Type 1 | 1 | 2007 | 16 | 0.020 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2007 | 21 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 55 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 55 | 0.020 |
Why?
| Appetite Regulation | 1 | 2007 | 14 | 0.020 |
Why?
| Somatomedins | 1 | 2007 | 29 | 0.020 |
Why?
| TNF Receptor-Associated Factor 1 | 1 | 2007 | 3 | 0.020 |
Why?
| STAT3 Transcription Factor | 1 | 2007 | 87 | 0.020 |
Why?
| Cluster Analysis | 1 | 2008 | 249 | 0.020 |
Why?
| Hormones | 1 | 2007 | 59 | 0.020 |
Why?
| Brain Chemistry | 1 | 2007 | 75 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2012 | 1679 | 0.020 |
Why?
| Mitochondria | 1 | 2011 | 489 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 36 | 0.020 |
Why?
| Osteotomy | 1 | 2007 | 35 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2007 | 198 | 0.020 |
Why?
| Nutrition Disorders | 1 | 2006 | 11 | 0.020 |
Why?
| Cell Transformation, Neoplastic | 1 | 2008 | 200 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 101 | 0.020 |
Why?
| Duodenal Neoplasms | 1 | 2005 | 15 | 0.020 |
Why?
| Choristoma | 1 | 2005 | 22 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2006 | 197 | 0.020 |
Why?
| Spleen | 1 | 2007 | 186 | 0.020 |
Why?
| Myometrium | 1 | 2005 | 15 | 0.020 |
Why?
| Intestinal Mucosa | 1 | 2007 | 259 | 0.020 |
Why?
| Chondrocytes | 1 | 2005 | 37 | 0.020 |
Why?
| Endometrium | 1 | 2005 | 43 | 0.020 |
Why?
| Epithelium | 1 | 2005 | 68 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 34 | 0.020 |
Why?
| Somatostatin | 1 | 2005 | 26 | 0.020 |
Why?
| Bony Callus | 1 | 2004 | 4 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2004 | 29 | 0.020 |
Why?
| Blood Glucose | 1 | 2007 | 488 | 0.020 |
Why?
| Meat | 1 | 2004 | 59 | 0.020 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2005 | 142 | 0.020 |
Why?
| Hemostasis | 1 | 2004 | 56 | 0.020 |
Why?
| Homocysteine | 1 | 2004 | 126 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2004 | 250 | 0.020 |
Why?
| DNA | 1 | 2007 | 581 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 657 | 0.010 |
Why?
| Molecular Structure | 1 | 2005 | 319 | 0.010 |
Why?
| Terminology as Topic | 1 | 2004 | 72 | 0.010 |
Why?
| Research | 1 | 2004 | 110 | 0.010 |
Why?
| Treatment Outcome | 1 | 2014 | 5604 | 0.010 |
Why?
| Osteopontin | 1 | 2002 | 16 | 0.010 |
Why?
| Intubation, Gastrointestinal | 1 | 2002 | 27 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 570 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2002 | 401 | 0.010 |
Why?
| Aged | 1 | 2004 | 10041 | 0.010 |
Why?
|
|
Badger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|